5750 |
Is TEVAR Safe and Durable in Long Term? |
Ju Han Kim |
Apr. 20. 23 |
5749 |
Is EVAR Safe and Durable in Long Term? |
Young-Guk Ko |
Apr. 20. 23 |
5748 |
Recent Updates of Long-term Outcomes After Surgical/Endovascular AAA Repair |
Ki-Hyun Jeon |
Apr. 20. 23 |
5747 |
My 30 Years Story - Caring for Patients With Symptomatic Vascular Disease |
John Robert Laird, Jr. |
Apr. 20. 23 |
5746 |
A Multi Center Analysis on Safety and Efficacy of BTK Everolimus-Eluting Stent from Taiwan |
Jen-Kuang Lee |
Apr. 20. 23 |
5745 |
Selection of Guidewires and Supporting Devices for BTK Interventions |
Jae-Hwan Lee |
Apr. 20. 23 |
5744 |
How I Manage Long Femoropopliteal Artery CTOs with EVT |
Chul-Min Ahn |
Apr. 20. 23 |
5743 |
Sustained Limus Release vs. Paclitaxel DCB Treatment in Symptomatic Peripheral Artery Disease: The Limus FLOW Randomized Controlled Trial |
Aloke V. Finn |
Apr. 20. 23 |
5742 |
Limiting Stent Length: Back to Spot Stenting |
Antonio Colombo |
Apr. 20. 23 |
5741 |
How Would You Define Stentable Long Lesion? |
Myeong-Ki Hong |
Apr. 20. 23 |